Human Metabolome Technologies, Inc. Stock
Equities
6090
JP3794530000
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
662 JPY | +0.46% | -2.93% | +3.44% |
Sales 2022 | 1.22B 7.86M | Sales 2023 | 1.3B 8.35M | Capitalization | 4.42B 28.43M |
---|---|---|---|---|---|
Net income 2022 | 267M 1.72M | Net income 2023 | 285M 1.83M | EV / Sales 2022 | 2.48 x |
Net cash position 2022 | 1.27B 8.17M | Net cash position 2023 | 1.43B 9.19M | EV / Sales 2023 | 2.31 x |
P/E ratio 2022 |
16.1
x | P/E ratio 2023 |
15.5
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
1.34% | Free-Float | 80.56% |
1 day | +0.46% | ||
1 week | -2.93% | ||
Current month | +1.07% | ||
1 month | +3.12% | ||
6 months | -4.47% | ||
Current year | +3.44% |
Managers | Title | Age | Since |
---|---|---|---|
President | 55 | 18-02-28 | |
Tomomi Ishihara
ADM | Chief Administrative Officer | - | - |
Takaomi Fukuhara
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Yasuhiro Ohata
BRD | Director/Board Member | 59 | 20-06-30 |
Corporate Officer/Principal | 49 | 05-06-30 | |
Toshio Nagae
BRD | Director/Board Member | 80 | 17-06-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 662 | +0.46% | 1,900 |
24-04-24 | 659 | -0.45% | 4,100 |
24-04-23 | 662 | +0.15% | 900 |
24-04-22 | 661 | -1.49% | 2,600 |
24-04-19 | 671 | -1.61% | 22,000 |
Delayed Quote Japan Exchange, April 25, 2024 at 02:00 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+3.44% | 25.14M | |
+1.12% | 43.84B | |
+6.77% | 41.68B | |
+45.26% | 41.25B | |
-11.96% | 27.04B | |
+6.01% | 25.53B | |
-24.92% | 18.18B | |
-3.63% | 12.29B | |
+27.16% | 12.29B | |
+7.30% | 11.15B |
- Stock Market
- Equities
- 6090 Stock